Articles

• Select this article
  • W J Gullick

  The Type 1 growth factor receptors and their ligands considered as a complex system.

  Endocr Relat Cancer 8 (2) 75-82, doi:10.1677/erc.0.0080075
  • Abstract
  • Full Text (PDF)
• • C T Kuan,
  • C J Wikstrand,
  • and D D Bigner

  EGF mutant receptor vIII as a molecular target in cancer therapy.

  Endocr Relat Cancer 8 (2) 83-96, doi:10.1677/erc.0.0080083
  • Full Text (PDF)
• Select this article
  • L R Howe,
  • K Subbaramaiah,
  • A M Brown,
  • and A J Dannenberg

  Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.

  Endocr Relat Cancer 8 (2) 97-114, doi:10.1677/erc.0.0080097
  • Abstract
  • Full Text (PDF)
• Select this article
  • X Yang,
  • L Yan,
  • and N E Davidson

  DNA methylation in breast cancer.

  Endocr Relat Cancer 8 (2) 115-27, doi:10.1677/erc.0.0080115
  • Abstract
  • Full Text (PDF)
• Select this article
  • P This,
  • A De La Rochefordi√®re,
  • K Clough,
  • A Fourquet,
  • H Magdelenat,
  • and Breast Cancer Group of the Institut Curie

  Phytoestrogens after breast cancer.

  Endocr Relat Cancer 8 (2) 129-34, doi:10.1677/erc.0.0080129
  • Abstract
  • Full Text (PDF)
• Select this article
  • F Orlandi,
  • P Caraci,
  • A Mussa,
  • E Saggiorato,
  • G Pancani,
  • and A Angeli

  Treatment of medullary thyroid carcinoma: an update.

  Endocr Relat Cancer 8 (2) 135-47, doi:10.1677/erc.0.0080135
  • Abstract
  • Full Text (PDF)